Dan Rujescu

· Martin Luther University Halle-Wittenberg
111h 指数
60,834总引用
901发文
415i10

简介

Dan Rujescu has been Professor of Psychiatry and Psychotherapeutic Medicine at MedUniVenna and Head of the Division of General Psychiatry since May 2021. He completed his medical studies at the Universities of Heidelberg and Essen. From 1993-1995 he worked as a doctor at the Psychiatry Clinic at the University of Mainz. He then worked at the Psychiatric Clinic at the Luwig-Maximilians-University in Munich, as Head of the Department of Molecular and Clinical Neurobiology, Senior Physician, Specialist in Psychiatry and Psychotherapy, Professor of Psychiatry, Head of the Alzheimer's Memorial and Deputy Head of the Department. From 2012 to spring 2021 he held the chair in the Department of Psychiatry, Psychotherapy and Psychosomatics at the University of Halle, Germany. He refers to an extensive publication list with more than 450 original publications with a Hirsch factor of over 80 (e.g. Nature; Nature Genetics). He has top-class national and especially international collaborations and has so far raised more than €9.2 million in third-party funding, including eight EU-funded projects, three genome-wide genotyping initiatives by the Wellcome Trust (WTCCC2/3), a DFG priority program, and one project of the Bavarian Research Foundation, two RO1 projects of the National Institutes of Mental Health (USA), a project of the National Genome Research Network and a project of the Federal Ministry of Education and Research (BMBF). Dan Rujescu is a member of several national and international scientific societies. He is Chair of the Genetics Working Group and Editor-in-Chief of the World Journal of Biological Psychiatry of the World Society of Biological Psychiatry (WFSBP). He is also PI of the EU-FP7 project "Optimizing current therapeutic approaches to schizophrenia. Optimization of Treatment and Management of Schizophrenia (OPTIMISE)" and the EU-FP7 consortium "Pharmacogenomic bio-markers as clinical decision making tools for clozapine". treatment of schizophrenia (CRESTAR)" (OPTIMISE)". Total > 470 original pulcations with a cumulative impact factor > 4,100; Hirsch Index: >80 Web of Science • Member of the "Highly Cited Researchers" 2018 worldwide (365 from Germany) (Clarivate Analytics) • 2nd place in the 'most cited minds' in Germany in the field of 'non-clinical neurosciences' in the years 2007-2011 (source: Laborjournal 01/2014) • 3rd place in the 'most cited minds' in Germany in the field of "Behaviour and Cognitive Neurobiology" 2009-2013 (source: Laborjournal 04/2015) • 8th place in the 'most cited minds' in Germany in the field of 'human genetics' 2007-2010 (source: Laborjournal 12/2013) and 21st place in the years 2012-2016 (source: Laborjournal 04/2018) • 8th place in the 'most cited minds' in Germany in the field of 'clinical neurosciences' 2012-2016 (Source: Laborjournal 05/2018)

研究方向

Genetic Associations and EpidemiologySchizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disordersGenetics and Neurodevelopmental Disorders

Martin Luther University Halle-Wittenberg学位项目

该教授任职院校的热门项目 (PhD/Master 优先)

数据来源: OpenAlex + ORCID + Wikidata · 数据质量: verified

登录后开启学术探索

收藏教授 / 论文 / 学科排名, 订阅研究方向更新。登录后开启这些能力。

已有账号?